NL6911089A - - Google Patents

Info

Publication number
NL6911089A
NL6911089A NL6911089A NL6911089A NL6911089A NL 6911089 A NL6911089 A NL 6911089A NL 6911089 A NL6911089 A NL 6911089A NL 6911089 A NL6911089 A NL 6911089A NL 6911089 A NL6911089 A NL 6911089A
Authority
NL
Netherlands
Application number
NL6911089A
Other versions
NL160485B (nl
NL160485C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6911089A publication Critical patent/NL6911089A/xx
Publication of NL160485B publication Critical patent/NL160485B/xx
Application granted granted Critical
Publication of NL160485C publication Critical patent/NL160485C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/535—Organo-phosphoranes
    • C07F9/5352—Phosphoranes containing the structure P=C-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL6911089.A 1968-07-24 1969-07-18 Werkwijze ter bereiding van farmaceutische preparaten met anti-inflammatoire, analgetische en anti-pyretische wer- king, alsmede door toepassing van deze werkwijze verkregen voorwerpen. NL160485C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74707168A 1968-07-24 1968-07-24

Publications (3)

Publication Number Publication Date
NL6911089A true NL6911089A (ja) 1970-01-27
NL160485B NL160485B (nl) 1979-06-15
NL160485C NL160485C (nl) 1979-11-15

Family

ID=25003550

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6911089.A NL160485C (nl) 1968-07-24 1969-07-18 Werkwijze ter bereiding van farmaceutische preparaten met anti-inflammatoire, analgetische en anti-pyretische wer- king, alsmede door toepassing van deze werkwijze verkregen voorwerpen.

Country Status (7)

Country Link
US (1) US3562336A (ja)
JP (2) JPS5231868B1 (ja)
CH (1) CH521935A (ja)
ES (1) ES368572A1 (ja)
IL (1) IL32225A (ja)
NL (1) NL160485C (ja)
SE (1) SE382045B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068541A1 (ja) * 1969-10-09 1971-08-27 Syntex Corp

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207241A (en) * 1967-01-13 1980-06-10 Syntex Corporation 2-Naphthyl acetic acid derivatives and compositions and methods thereof
US3681432A (en) * 1969-09-30 1972-08-01 Syntex Corp 2-formyl-(6-methoxy-2-naphthyl) acetic acid
US4001301A (en) * 1971-11-04 1977-01-04 Syntex Corporation 6-substituted 2-naphthyl acetic acid derivatives
US3969415A (en) * 1971-12-01 1976-07-13 Sandoz, Inc. 1-(2-Naphthyl)-2,3-butadien-1-ols
US3873718A (en) * 1973-03-29 1975-03-25 Syntex Corp Method for delaying the onset of, or postponing, parturition
US3943257A (en) * 1973-08-20 1976-03-09 Sandoz, Inc. 4-Alkyl-4-naphthyl butenes
US3994968A (en) * 1975-01-10 1976-11-30 Syntex Corporation 2-(5'-Halo-6'-methoxynaphth-2'-yl)-acrylic acid
US4912248A (en) * 1987-05-18 1990-03-27 The Procter & Gamble Company Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
US5286902A (en) * 1991-04-15 1994-02-15 Koch Industries, Inc. Process for preparation of 2-(6-methoxy-2-naphthyl)propionic acid and intermediates therefor utilizing 2,6-diisopropylnaphthalene
US5792886A (en) * 1997-01-08 1998-08-11 Albemarle Corporation Production of racemic 2-(6-methoxy-2-naphthyl) propionic acid of precursors thereof
US6096920A (en) * 1997-01-08 2000-08-01 Albemarle Corporation Preparation of carboxylic compounds and their derivatives
US6080888A (en) * 1997-01-08 2000-06-27 Albemarle Corporation Preparation of olefinic compounds and carboxylic derivatives thereof
US5874614A (en) * 1997-12-11 1999-02-23 Albemarle Corporation Sodium (S)-2-(6-methoxy-2-naphthyl)propionate monohydrate
US5859292A (en) * 1997-12-11 1999-01-12 Albemarle Corporation Preparation of high purity sodium (S)-2(6-methoxy-2-naphthyl)propionate
US20060106102A1 (en) * 2002-06-07 2006-05-18 Eric Morand Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068541A1 (ja) * 1969-10-09 1971-08-27 Syntex Corp

Also Published As

Publication number Publication date
SE382045B (sv) 1976-01-12
ES368572A1 (es) 1971-05-01
NL160485B (nl) 1979-06-15
US3562336A (en) 1971-02-09
JPS5231868B1 (ja) 1977-08-17
IL32225A (en) 1973-08-29
JPS5241258B1 (ja) 1977-10-17
NL160485C (nl) 1979-11-15
IL32225A0 (en) 1969-07-30
CH521935A (de) 1972-04-30

Similar Documents

Publication Publication Date Title
AU1946070A (ja)
AU428130B2 (ja)
AU2374870A (ja)
AU5184069A (ja)
AU6168869A (ja)
AU6171569A (ja)
AU429879B2 (ja)
AU416157B2 (ja)
AU2581067A (ja)
AU4811568A (ja)
AU421558B1 (ja)
AU2580267A (ja)
AU3789668A (ja)
AU3224368A (ja)
AR203075Q (ja)
AU4744468A (ja)
AU479393A (ja)
BE708888A (ja)
AU463027A (ja)
AU4503667A (ja)
BE709484A (ja)
AU479894A (ja)
AU4464266A (ja)
BE709479A (ja)
BE709446A (ja)

Legal Events

Date Code Title Description
SNR Assignments of patents or rights arising from examined patent applications

Owner name: SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED

NL80 Information provided on patent owner name for an already discontinued patent

Owner name: SYNTEX

V4 Discontinued because of reaching the maximum lifetime of a patent